-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-017 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-017 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EG-017 in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-501 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-501 in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EG-501 in Systemic Lupus Erythematosus Drug Details:EG-501 is under development for the...
-
Sector Analysis
Ethylene Glycol Industry Capacity and Capital Expenditure Forecasts with Details of All Active and Planned Plants to 2028
Ethylene Glycol Industry Capacity & CapEx Overview The Ethylene Glycol industry capacity was 60.06 million tonnes per annum (mtpa) in 2023 and it is expected to increase at an AAGR of more than 5% during 2023-2028. Around 40 planned and announced plants are slated to come online by 2028, primarily in Asia and the Middle East. This will boost the market growth during the forecast years. Ethylene Glycol Industry Capacity and CapEx Outlook, 2023-2028 (mtpa) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-001 in Idiopathic Interstitial Pneumonia (IIP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-001 in Idiopathic Interstitial Pneumonia (IIP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EG-001 in Idiopathic Interstitial Pneumonia (IIP)Drug Details:EG-001 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dapirolizumab Pegol in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dapirolizumab Pegol in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dapirolizumab Pegol in Systemic Lupus Erythematosus Drug Details: Dapirolizumab pegol...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Volrustomig in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Volrustomig in Gastric Cancer Drug Details: MEDI-5752 is under development for the treatment of solid...
-
Product Insights
NewSensory Disorders – Drugs In Development, 2024
Empower your strategies with our Sensory Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Sensory Disorders or sensory processing disorders (SPD) is a neurological condition in children that affects the sensory stimuli of brain. It is also known as sensory integration dysfunction causing an increased or decreased sensitivity to light, smell, taste, sound, and touch. It is divided into 8 different types: proprioception, vestibular, interoception, and five senses. Hyposensitivity and hypersensitivity are observed in children. As...
-
Sector Analysis
Esophagoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033
Esophagoscopes Market Report Overview The Esophagoscopes market size was valued at $12.9 million in 2023. An Esophagoscope is an endoscope that is inserted through the mouth or nares into the esophagus. This allows visualization of the esophageal mucosa from the upper esophageal sphincter to the esophageal gastric junction or EG junction. The market will grow at a CAGR of more than 2% during 2023-2033. Esophagoscopes Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Esophagoscopes...
-
Product Insights
NewNeuromuscular Disorders – Drugs In Development, 2024
Empower your strategies with our Neuromuscular Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Neuromuscular disorders are conditions that affect the function of the nerves and muscles in the body. They can cause muscle weakness, fatigue, pain, spasms, and other symptoms. Neuromuscular disorders can be inherited or acquired, and they can affect different parts of the neuromuscular system, such as the peripheral nerves, the skeletal muscles, or the neuromuscular junction. Some examples of neuromuscular disorders are...
-
Sector Analysis
Ethylene Glycol (EG) Industry Outlook in Argentina to 2028 – Market Size, Price Trends and Trade Balance
What is covered in the report about the “Argentina Ethylene Glycol (EG) Industry”? GlobalData’s report, “Ethylene Glycol (EG) Industry Outlook in Argentina to 2028 - Market Size, Price Trends and Trade Balance”, provides up to date in-depth information on Argentina’s Ethylene Glycol (EG) industry. The report presents major market trends. The report offers historical and forecast market size, demand and production forecasts, end-use demand details, price trends, trade balance data. *Note: This is an on-demand report and will be delivered...